barchester healthcare limited
barchester healthcare limited Company Information
Company Number
02792285
Next Accounts
Sep 2025
Shareholders
barchester holdco (jersey) ltd
Group Structure
View All
Industry
Activities of head offices
Registered Address
3rd floor the aspect, finsbury square, london, EC2A 1AS
Website
http://bhcfoundation.org.ukbarchester healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of BARCHESTER HEALTHCARE LIMITED at £748.3m based on a Turnover of £871m and 0.86x industry multiple (adjusted for size and gross margin).
barchester healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of BARCHESTER HEALTHCARE LIMITED at £806.5m based on an EBITDA of £118.7m and a 6.8x industry multiple (adjusted for size and gross margin).
barchester healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of BARCHESTER HEALTHCARE LIMITED at £497.7m based on Net Assets of £236.3m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Barchester Healthcare Limited Overview
Barchester Healthcare Limited is a live company located in london, EC2A 1AS with a Companies House number of 02792285. It operates in the activities of head offices sector, SIC Code 70100. Founded in February 1993, it's largest shareholder is barchester holdco (jersey) ltd with a 100% stake. Barchester Healthcare Limited is a mature, mega sized company, Pomanda has estimated its turnover at £871m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Barchester Healthcare Limited Health Check
Pomanda's financial health check has awarded Barchester Healthcare Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 5 areas for improvement. Company Health Check FAQs
7 Strong
0 Regular
5 Weak
Size
annual sales of £871m, make it larger than the average company (£20.2m)
£871m - Barchester Healthcare Limited
£20.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (7.4%)
10% - Barchester Healthcare Limited
7.4% - Industry AVG
Production
with a gross margin of 18.1%, this company has a higher cost of product (33.7%)
18.1% - Barchester Healthcare Limited
33.7% - Industry AVG
Profitability
an operating margin of 8.7% make it more profitable than the average company (5.9%)
8.7% - Barchester Healthcare Limited
5.9% - Industry AVG
Employees
with 16250 employees, this is above the industry average (110)
16250 - Barchester Healthcare Limited
110 - Industry AVG
Pay Structure
on an average salary of £29k, the company has a lower pay structure (£49.9k)
£29k - Barchester Healthcare Limited
£49.9k - Industry AVG
Efficiency
resulting in sales per employee of £53.6k, this is less efficient (£204.7k)
£53.6k - Barchester Healthcare Limited
£204.7k - Industry AVG
Debtor Days
it gets paid by customers after 13 days, this is earlier than average (45 days)
13 days - Barchester Healthcare Limited
45 days - Industry AVG
Creditor Days
its suppliers are paid after 7 days, this is quicker than average (42 days)
7 days - Barchester Healthcare Limited
42 days - Industry AVG
Stock Days
it holds stock equivalent to 4 days, this is less than average (48 days)
4 days - Barchester Healthcare Limited
48 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 8 weeks, this is less cash available to meet short term requirements (15 weeks)
8 weeks - Barchester Healthcare Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 69.6%, this is a higher level of debt than the average (55.6%)
69.6% - Barchester Healthcare Limited
55.6% - Industry AVG
BARCHESTER HEALTHCARE LIMITED financials
Barchester Healthcare Limited's latest turnover from December 2023 is £871 million and the company has net assets of £236.3 million. According to their latest financial statements, Barchester Healthcare Limited has 16,250 employees and maintains cash reserves of £31.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 871,047,000 | 766,761,000 | 675,914,000 | 663,395,000 | 657,619,000 | 621,268,000 | 591,189,000 | 563,937,000 | 535,612,000 | 523,400,000 | 495,490,000 | 463,161,000 | 446,864,000 | 432,724,000 | 413,115,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 713,636,000 | 648,457,000 | 595,310,000 | 575,100,000 | 567,391,000 | 538,020,000 | 513,552,000 | 501,824,000 | 482,183,000 | 469,194,000 | 440,258,000 | 397,524,000 | 377,182,000 | 356,834,000 | 347,327,000 |
| Gross Profit | 157,411,000 | 118,304,000 | 80,604,000 | 88,295,000 | 90,228,000 | 83,248,000 | 77,637,000 | 62,113,000 | 53,429,000 | 54,206,000 | 55,232,000 | 65,637,000 | 69,682,000 | 75,890,000 | 65,788,000 |
| Admin Expenses | 81,789,000 | 54,130,000 | 48,713,000 | 45,606,000 | 49,184,000 | 48,116,000 | 53,573,000 | 41,247,000 | 35,323,000 | 34,376,000 | 32,062,000 | 34,653,000 | 27,132,000 | 28,963,000 | 29,386,000 |
| Operating Profit | 75,622,000 | 64,174,000 | 31,891,000 | 42,689,000 | 41,044,000 | 35,132,000 | 24,064,000 | 20,866,000 | 18,106,000 | 19,830,000 | 23,170,000 | 30,984,000 | 42,550,000 | 46,927,000 | 36,402,000 |
| Interest Payable | 37,498,000 | 32,328,000 | 27,822,000 | 23,518,000 | 19,259,000 | 17,839,000 | 17,204,000 | 17,130,000 | 15,153,000 | 12,499,000 | 2,496,000 | 3,991,000 | 4,956,000 | 6,252,000 | 9,513,000 |
| Interest Receivable | 903,000 | 1,000 | 56,000 | 3,000 | 10,000 | 28,000 | 42,000 | 95,000 | 118,000 | 136,000 | 342,000 | ||||
| Pre-Tax Profit | 39,027,000 | 31,847,000 | 4,069,000 | 19,171,000 | 21,785,000 | 17,349,000 | 6,860,000 | 3,739,000 | 2,963,000 | 7,359,000 | 20,716,000 | 27,087,000 | 37,712,000 | 40,811,000 | 27,231,000 |
| Tax | -16,546,000 | -9,932,000 | -6,639,000 | -7,262,000 | -6,004,000 | -7,040,000 | -4,934,000 | -1,793,000 | -2,207,000 | -5,354,000 | -4,471,000 | -7,554,000 | -9,504,000 | -9,869,000 | -5,953,000 |
| Profit After Tax | 22,481,000 | 21,915,000 | -2,570,000 | 11,909,000 | 15,781,000 | 10,309,000 | 1,926,000 | 1,946,000 | 756,000 | 2,005,000 | 16,245,000 | 19,533,000 | 28,208,000 | 30,942,000 | 21,278,000 |
| Dividends Paid | 9,141,000 | 1,000,000 | |||||||||||||
| Retained Profit | 22,481,000 | 21,915,000 | -2,570,000 | 11,909,000 | 6,640,000 | 10,309,000 | 926,000 | 1,946,000 | 756,000 | 2,005,000 | 16,245,000 | 19,533,000 | 28,208,000 | 30,942,000 | 21,278,000 |
| Employee Costs | 470,681,000 | 395,014,000 | 389,969,000 | 372,841,000 | 341,718,000 | 323,169,000 | 303,467,000 | 286,324,000 | 270,312,000 | 265,550,000 | 249,991,000 | 230,578,000 | 215,441,000 | 212,879,000 | 208,607,000 |
| Number Of Employees | 16,250 | 14,947 | 14,962 | 15,427 | 15,813 | 15,754 | 15,462 | 15,710 | 17,623 | 18,683 | 16,987 | 16,248 | 14,728 | 14,504 | 14,127 |
| EBITDA* | 118,667,000 | 105,211,000 | 73,806,000 | 82,708,000 | 78,716,000 | 69,484,000 | 54,523,000 | 48,159,000 | 43,230,000 | 43,479,000 | 41,889,000 | 48,733,000 | 60,948,000 | 62,197,000 | 50,826,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 431,673,000 | 386,626,000 | 354,631,000 | 320,558,000 | 284,415,000 | 258,220,000 | 246,800,000 | 244,149,000 | 236,081,000 | 205,043,000 | 85,623,000 | 87,734,000 | 82,961,000 | 78,969,000 | 72,155,000 |
| Intangible Assets | 4,669,000 | 10,831,000 | 16,992,000 | 23,154,000 | 29,316,000 | 35,477,000 | 41,639,000 | 47,800,000 | 53,962,000 | 60,907,000 | 130,693,000 | 139,119,000 | 147,499,000 | 154,958,000 | 163,338,000 |
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 436,342,000 | 397,457,000 | 371,623,000 | 343,712,000 | 313,731,000 | 293,697,000 | 288,439,000 | 291,949,000 | 290,043,000 | 265,950,000 | 216,316,000 | 226,853,000 | 230,460,000 | 233,927,000 | 235,493,000 |
| Stock & work in progress | 8,665,000 | 7,648,000 | 6,894,000 | 5,791,000 | 5,117,000 | 4,808,000 | 3,487,000 | 4,106,000 | 5,514,000 | 5,807,000 | 6,429,000 | 7,046,000 | 7,053,000 | 6,757,000 | 4,945,000 |
| Trade Debtors | 33,285,000 | 39,179,000 | 33,634,000 | 30,011,000 | 30,640,000 | 32,348,000 | 30,223,000 | 25,952,000 | 24,408,000 | 23,790,000 | 9,869,000 | 7,888,000 | 17,438,000 | 17,323,000 | 16,812,000 |
| Group Debtors | 224,218,000 | 178,817,000 | 163,091,000 | 134,485,000 | 32,175,000 | 26,565,000 | 31,059,000 | 37,171,000 | 33,419,000 | 32,846,000 | 33,193,000 | 179,595,000 | 178,754,000 | 178,796,000 | 153,916,000 |
| Misc Debtors | 43,719,000 | 40,982,000 | 38,647,000 | 35,583,000 | 31,230,000 | 30,914,000 | 28,140,000 | 29,342,000 | 29,193,000 | 29,951,000 | 32,322,000 | 27,867,000 | 23,584,000 | 20,966,000 | 18,892,000 |
| Cash | 31,119,000 | 24,256,000 | 25,549,000 | 17,106,000 | 59,899,000 | 27,858,000 | 19,262,000 | 12,267,000 | 17,451,000 | 11,037,000 | 13,570,000 | 10,193,000 | 16,762,000 | 25,467,000 | 19,349,000 |
| misc current assets | |||||||||||||||
| total current assets | 341,006,000 | 290,882,000 | 267,815,000 | 222,976,000 | 159,061,000 | 122,493,000 | 112,171,000 | 108,838,000 | 109,985,000 | 103,431,000 | 95,383,000 | 232,589,000 | 243,591,000 | 249,309,000 | 213,914,000 |
| total assets | 777,348,000 | 688,339,000 | 639,438,000 | 566,688,000 | 472,792,000 | 416,190,000 | 400,610,000 | 400,787,000 | 400,028,000 | 369,381,000 | 311,699,000 | 459,442,000 | 474,051,000 | 483,236,000 | 449,407,000 |
| Bank overdraft | |||||||||||||||
| Bank loan | 5,000,000 | 15,000,000 | 20,802,000 | 12,916,000 | 10,074,000 | ||||||||||
| Trade Creditors | 13,882,000 | 14,924,000 | 12,896,000 | 8,388,000 | 11,190,000 | 11,362,000 | 10,695,000 | 7,389,000 | 5,912,000 | 5,045,000 | 5,882,000 | 5,235,000 | |||
| Group/Directors Accounts | 50,356,000 | 48,370,000 | 52,812,000 | 51,965,000 | 35,319,000 | 30,811,000 | 39,381,000 | 60,060,000 | 62,717,000 | 62,657,000 | |||||
| other short term finances | 5,063,000 | 3,907,000 | 1,711,000 | 1,022,000 | 762,000 | 609,000 | 14,433,000 | 853,000 | 295,000 | ||||||
| hp & lease commitments | 3,108,000 | 1,962,000 | 8,359,000 | 1,413,000 | 1,371,000 | 1,437,000 | 909,000 | ||||||||
| other current liabilities | 114,392,000 | 101,955,000 | 108,915,000 | 99,992,000 | 85,164,000 | 67,911,000 | 65,659,000 | 57,221,000 | 50,173,000 | 50,871,000 | 97,289,000 | 155,101,000 | 161,814,000 | 157,361,000 | 130,452,000 |
| total current liabilities | 183,693,000 | 169,156,000 | 177,731,000 | 162,056,000 | 133,635,000 | 111,106,000 | 116,497,000 | 125,279,000 | 133,235,000 | 119,426,000 | 116,530,000 | 176,749,000 | 183,987,000 | 171,714,000 | 141,730,000 |
| loans | 237,268,000 | 189,665,000 | 168,395,000 | 161,036,000 | 160,929,000 | 153,592,000 | 137,169,000 | 32,933,000 | 13,688,000 | 57,194,000 | 136,022,000 | 172,800,000 | |||
| hp & lease commitments | 348,987,000 | 312,610,000 | 280,247,000 | 15,000,000 | 3,344,000 | 2,685,000 | 2,586,000 | 2,560,000 | |||||||
| Accruals and Deferred Income | 8,528,000 | 11,107,000 | 14,299,000 | ||||||||||||
| other liabilities | |||||||||||||||
| provisions | 8,326,000 | 4,195,000 | 1,933,000 | 772,000 | 1,555,000 | 2,247,000 | 575,000 | 2,599,000 | 3,139,000 | 3,353,000 | 13,602,000 | 14,372,000 | 2,228,000 | 2,964,000 | 3,456,000 |
| total long term liabilities | 357,313,000 | 316,805,000 | 282,180,000 | 238,040,000 | 191,220,000 | 170,642,000 | 161,611,000 | 163,528,000 | 156,731,000 | 140,522,000 | 24,734,000 | 17,530,000 | 44,239,000 | 94,100,000 | 121,427,000 |
| total liabilities | 541,006,000 | 485,961,000 | 459,911,000 | 400,096,000 | 324,855,000 | 281,748,000 | 278,108,000 | 288,807,000 | 289,966,000 | 259,948,000 | 141,264,000 | 194,279,000 | 228,226,000 | 265,814,000 | 263,157,000 |
| net assets | 236,342,000 | 202,378,000 | 179,527,000 | 166,592,000 | 147,937,000 | 134,442,000 | 122,502,000 | 111,980,000 | 110,062,000 | 109,433,000 | 170,435,000 | 265,163,000 | 245,825,000 | 217,422,000 | 186,250,000 |
| total shareholders funds | 236,342,000 | 202,378,000 | 179,527,000 | 166,592,000 | 147,937,000 | 134,442,000 | 122,502,000 | 111,980,000 | 110,062,000 | 109,433,000 | 170,435,000 | 265,163,000 | 245,825,000 | 217,422,000 | 186,250,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 75,622,000 | 64,174,000 | 31,891,000 | 42,689,000 | 41,044,000 | 35,132,000 | 24,064,000 | 20,866,000 | 18,106,000 | 19,830,000 | 23,170,000 | 30,984,000 | 42,550,000 | 46,927,000 | 36,402,000 |
| Depreciation | 36,883,000 | 34,875,000 | 35,753,000 | 33,857,000 | 31,511,000 | 28,190,000 | 24,298,000 | 21,131,000 | 18,179,000 | 17,441,000 | 10,293,000 | 9,369,000 | 10,018,000 | 6,890,000 | 6,044,000 |
| Amortisation | 6,162,000 | 6,162,000 | 6,162,000 | 6,162,000 | 6,161,000 | 6,162,000 | 6,161,000 | 6,162,000 | 6,945,000 | 6,208,000 | 8,426,000 | 8,380,000 | 8,380,000 | 8,380,000 | 8,380,000 |
| Tax | -16,546,000 | -9,932,000 | -6,639,000 | -7,262,000 | -6,004,000 | -7,040,000 | -4,934,000 | -1,793,000 | -2,207,000 | -5,354,000 | -4,471,000 | -7,554,000 | -9,504,000 | -9,869,000 | -5,953,000 |
| Stock | 1,017,000 | 754,000 | 1,103,000 | 674,000 | 309,000 | 1,321,000 | -619,000 | -1,408,000 | -293,000 | -622,000 | -617,000 | -7,000 | 296,000 | 1,812,000 | 4,945,000 |
| Debtors | 42,244,000 | 23,606,000 | 35,293,000 | 106,034,000 | 4,218,000 | 405,000 | -3,043,000 | 5,445,000 | 433,000 | 11,203,000 | -139,966,000 | -4,426,000 | 2,691,000 | 27,465,000 | 189,620,000 |
| Creditors | -1,042,000 | 2,028,000 | 4,508,000 | -2,802,000 | -172,000 | 667,000 | 3,306,000 | 1,477,000 | 867,000 | -837,000 | 647,000 | 5,235,000 | |||
| Accruals and Deferred Income | 12,437,000 | -6,960,000 | 8,923,000 | 14,828,000 | 17,253,000 | 2,252,000 | 8,438,000 | 7,048,000 | -698,000 | -46,418,000 | -57,812,000 | -15,241,000 | 1,874,000 | 23,717,000 | 144,751,000 |
| Deferred Taxes & Provisions | 4,131,000 | 2,262,000 | 1,161,000 | -783,000 | -692,000 | 1,672,000 | -2,024,000 | -540,000 | -214,000 | -10,249,000 | -770,000 | 12,144,000 | -736,000 | -492,000 | 3,456,000 |
| Cash flow from operations | 74,386,000 | 68,249,000 | 45,363,000 | -20,019,000 | 84,574,000 | 65,309,000 | 62,971,000 | 50,314,000 | 40,838,000 | -29,960,000 | 120,066,000 | 47,750,000 | 49,595,000 | 46,276,000 | -1,485,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | -34,218,000 | 560,000 | 398,000 | ||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | -34,218,000 | 560,000 | 398,000 | ||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | -5,000,000 | -10,000,000 | -5,802,000 | 7,886,000 | 2,842,000 | 10,074,000 | |||||||||
| Group/Directors Accounts | 1,986,000 | -4,442,000 | 847,000 | 16,646,000 | 4,508,000 | -8,570,000 | -20,679,000 | -2,657,000 | 60,000 | 62,657,000 | |||||
| Other Short Term Loans | 1,156,000 | 3,907,000 | -1,711,000 | 1,711,000 | -1,022,000 | 260,000 | 153,000 | -13,824,000 | 13,580,000 | 853,000 | -295,000 | 295,000 | |||
| Long term loans | -237,268,000 | 47,603,000 | 21,270,000 | 7,359,000 | 107,000 | 7,337,000 | 16,423,000 | 104,236,000 | 19,245,000 | -43,506,000 | -78,828,000 | -36,778,000 | 172,800,000 | ||
| Hire Purchase and Lease Commitments | 36,377,000 | 29,255,000 | 283,355,000 | -1,962,000 | 1,962,000 | -23,359,000 | 18,602,000 | 701,000 | 33,000 | 554,000 | 3,469,000 | ||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -36,595,000 | -32,327,000 | -27,822,000 | -23,518,000 | -19,259,000 | -17,783,000 | -17,204,000 | -17,127,000 | -15,143,000 | -12,471,000 | -2,454,000 | -3,896,000 | -4,838,000 | -6,116,000 | -9,171,000 |
| cash flow from financing | 14,407,000 | -2,671,000 | 32,906,000 | 47,226,000 | 14,314,000 | -17,103,000 | -28,027,000 | -26,299,000 | 14,793,000 | 63,909,000 | -85,580,000 | -52,698,000 | -75,552,000 | -39,563,000 | 342,439,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 6,863,000 | -1,293,000 | 8,443,000 | -42,793,000 | 32,041,000 | 8,596,000 | 6,995,000 | -5,184,000 | 6,414,000 | -2,533,000 | 3,377,000 | -6,569,000 | -8,705,000 | 6,118,000 | 19,349,000 |
| overdraft | |||||||||||||||
| change in cash | 6,863,000 | -1,293,000 | 8,443,000 | -42,793,000 | 32,041,000 | 8,596,000 | 6,995,000 | -5,184,000 | 6,414,000 | -2,533,000 | 3,377,000 | -6,569,000 | -8,705,000 | 6,118,000 | 19,349,000 |
barchester healthcare limited Credit Report and Business Information
Barchester Healthcare Limited Competitor Analysis
Perform a competitor analysis for barchester healthcare limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mega companies, companies in EC2A area or any other competitors across 12 key performance metrics.
barchester healthcare limited Ownership
BARCHESTER HEALTHCARE LIMITED group structure
Barchester Healthcare Limited has 4 subsidiary companies.
Ultimate parent company
GROVE LTD
#0051603
BARCHESTER HOLDCO (JERSEY) LTD
#0055031
2 parents
BARCHESTER HEALTHCARE LIMITED
02792285
4 subsidiaries
barchester healthcare limited directors
Barchester Healthcare Limited currently has 8 directors. The longest serving directors include Professor John Hegarty (Sep 2011) and Mr Anthony Bourne (Dec 2011).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor John Hegarty | United Kingdom | 75 years | Sep 2011 | - | Director |
| Mr Anthony Bourne | United Kingdom | 71 years | Dec 2011 | - | Director |
| Mr Keith Browne | Ireland | 56 years | Jan 2014 | - | Director |
| Dr Dr Hazlewood | United Kingdom | 59 years | Apr 2014 | - | Director |
| Mr Pete Calveley | 64 years | Jun 2014 | - | Director | |
| Mr John Coleman | United Kingdom | 72 years | Mar 2015 | - | Director |
| Mr Michael O'Reilly | United Kingdom | 64 years | Apr 2017 | - | Director |
| Mrs Sally Cabrini | 60 years | Sep 2024 | - | Director |
P&L
December 2023turnover
871m
+14%
operating profit
75.6m
+18%
gross margin
18.1%
+17.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
236.3m
+0.17%
total assets
777.3m
+0.13%
cash
31.1m
+0.28%
net assets
Total assets minus all liabilities
barchester healthcare limited company details
company number
02792285
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
February 1993
age
32
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
barchester healthcare plc (August 2002)
planvigil public limited company (July 1995)
accountant
-
auditor
KPMG LLP
address
3rd floor the aspect, finsbury square, london, EC2A 1AS
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
barchester healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 16 charges/mortgages relating to barchester healthcare limited. Currently there are 5 open charges and 11 have been satisfied in the past.
barchester healthcare limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BARCHESTER HEALTHCARE LIMITED. This can take several minutes, an email will notify you when this has completed.
barchester healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
